Education
About Us
Working with TipRanks
Follow Us
Shanghai Junshi Biosciences Co., Ltd. Class H (HK:1877)
:1877
Total Valuation
Shanghai Junshi Biosciences Co., Ltd. Class H has a market cap or net worth of HK$27.78B. The enterprise value is HK$11.48B.
Market CapHK$27.78B
Enterprise ValueHK$11.48B
Share Statistics
Shanghai Junshi Biosciences Co., Ltd. Class H has 219,295,700 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding219,295,700
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Shanghai Junshi Biosciences Co., Ltd. Class H’s return on equity (ROE) is ― and return on invested capital (ROIC) is ―.
Return on Equity (ROE)―
Return on Assets (ROA)―
Return on Invested Capital (ROIC)―
Return on Capital Employed (ROCE)―
Revenue Per Employee582.84K
Profits Per Employee-885.74K
Employee Count2,578
Asset Turnover―
Inventory Turnover―
Valuation Ratios
The current PE Ratio of Shanghai Junshi Biosciences Co., Ltd. Class H is ―. Shanghai Junshi Biosciences Co., Ltd. Class H’s PEG ratio is ―.
PE Ratio―
PS Ratio8.00
PB Ratio―
Price to Fair Value―
Price to FCF―
Price to Operating Cash Flow―
PEG Ratio―
Income Statement
In the last 12 months, Shanghai Junshi Biosciences Co., Ltd. Class H had revenue of 1.50B and earned -2.28B in profits. Earnings per share was -2.32.
Revenue1.50B
Gross Profit835.26M
Operating Income-2.46B
Pretax Income-2.49B
Net Income-2.28B
EBITDA-2.16B
Earnings Per Share (EPS)-2.32
Cash Flow
In the last 12 months, operating cash flow was -1.21B and capital expenditures -411.33M, giving a free cash flow of -1.41B billion.
Operating Cash Flow-1.21B
Free Cash Flow-1.41B
Free Cash Flow per Share-6.42
Dividends & Yields
Shanghai Junshi Biosciences Co., Ltd. Class H pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.62
52-Week Price Change59.30%
50-Day Moving Average14.31
200-Day Moving Average12.88
Relative Strength Index (RSI)56.21
Average Volume (3m)2.08M
Important Dates
Shanghai Junshi Biosciences Co., Ltd. Class H upcoming earnings date is Apr 25, 2025, TBA Not Confirmed.
Last Earnings DateMar 27, 2025
Next Earnings DateApr 25, 2025
Ex-Dividend Date―
Financial Position
Shanghai Junshi Biosciences Co., Ltd. Class H as a current ratio of ―, with Debt / Equity ratio of ―
Current Ratio―
Quick Ratio―
Debt to Market Cap―
Net Debt to EBITDA―
Interest Coverage Ratio―
Taxes
In the past 12 months, Shanghai Junshi Biosciences Co., Ltd. Class H has paid 43.99M in taxes.
Income Tax43.99M
Effective Tax Rate―
Enterprise Valuation
Shanghai Junshi Biosciences Co., Ltd. Class H EV to EBITDA ratio is ―, with an EV/FCF ratio of ―.
EV to Sales―
EV to EBITDA―
EV to Free Cash Flow―
EV to Operating Cash Flow―
Balance Sheet
Shanghai Junshi Biosciences Co., Ltd. Class H has HK$3.31B in cash and marketable securities with ¥730.76M in debt, giving a net cash position of -HK$742.03M billion.
Cash & Marketable SecuritiesHK$3.31B
Total Debt¥730.76M
Net Cash-HK$742.03M
Net Cash Per Share-HK$3.38
Tangible Book Value Per Share―
Margins
Gross margin is ―, with operating margin of ―, and net profit margin of ―.
Gross Margin―
Operating Margin―
Pretax Margin―
Net Profit Margin―
EBITDA Margin―
EBIT Margin―
Analyst Forecast
The average price target for Shanghai Junshi Biosciences Co., Ltd. Class H is HK$11.00, which is 11.43% higher than the current price. The consensus rating is Moderate Sell
Price TargetHK$11.00
Price Target Upside-26.47% Downside
Analyst ConsensusModerate Sell
Analyst Count0
Revenue Growth Forecast27.82%
EPS Growth Forecast44.86%